The use of asciminib versus ponatinib for multiresistant CML VJHemOnc – Video Journal of Hematology & HemOnc 2:51 2 years ago 1 262 Далее Скачать
Toxicity profile of bosutinib in pediatric patients with R/R CML VJHemOnc – Video Journal of Hematology & HemOnc 1:41 1 year ago 71 Далее Скачать
5-year update of BFORE: bosutinib vs imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 535 Далее Скачать
Tolerability of bosutinib vs asciminib in heavily pre-treated patients with CML VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 185 Далее Скачать
Outcomes of patients with CML-CP treated with ponatinib vs 2G-TKIs in the third-line setting VJHemOnc – Video Journal of Hematology & HemOnc 2:49 1 year ago 150 Далее Скачать
Ponatinib versus ascimininib in the third-line treatment of CML VJHemOnc – Video Journal of Hematology & HemOnc 1:17 2 years ago 509 Далее Скачать
Phase I study of olverembatinib in patients with R/R CML & Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 4:23 1 year ago 297 Далее Скачать
Five-year follow-up data from the BFORE trial: bosutinib versus imatinib in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:54 2 years ago 243 Далее Скачать
Ponatinib in chronic-phase CML patients with prior second generation TKI exposure VJHemOnc – Video Journal of Hematology & HemOnc 4:44 4 years ago 324 Далее Скачать
OPTIC: Ponatinib in chronic-phase CML VJHemOnc – Video Journal of Hematology & HemOnc 1:37 3 years ago 257 Далее Скачать
Safety of ponatinib in chronic-phase chronic myeloid leukemia (CML) patients VJHemOnc – Video Journal of Hematology & HemOnc 1:35 7 years ago 391 Далее Скачать
Bosutinib Versus Imatinib (CML) Follow Up Study - Carlo Gambacorti-Passerini, MD Oncology.TV 5:22 12 years ago 1 779 Далее Скачать
An update on olverembatinib in patients with R/R CML and Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 0:56 11 months ago 183 Далее Скачать
Targeting the T315I mutation with ponatinib to treat patients with R/R Ph+ ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:54 2 years ago 420 Далее Скачать
OPTIC: ponatinib in resistant chronic-phase CML VJHemOnc – Video Journal of Hematology & HemOnc 4:19 4 years ago 275 Далее Скачать
Bosutinib versus imatinib for newly diagnosed chronic phase CML: Bfore trial final 5-year results ecancer 7:53 3 years ago 368 Далее Скачать
Bosutinib Versus Imatinib for Newly Diagnosed CML: Initial Results from the BFORE Trial Oncology.TV 7:47 7 years ago 607 Далее Скачать
